Brief: Essa Pharma Provides Corporate Update And Reports Financial Results For Fiscal Q2 Ended March 31, 2023
09/05/2023 13:27
May 9 (Reuters) - Essa Pharma Inc EPIX.O :
* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL SECOND QUARTER ENDED MARCH 31, 2023
* CASH POSITION IS EXPECTED TO BE SUFFICIENT TO FUND CURRENT
AND
PLANNED OPERATIONS THROUGH 2025
* QTRLY LOSS PER SHARE $0.16
* Q2 EARNINGS PER SHARE VIEW $-0.21 -- REFINITIV IBES DATA
Source text for Eikon: ID:nCNWnLJ2Sa
Further company coverage: EPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics